Mechanical prostheses provided a long-term mortality benefit compared to biologic prostheses up to 70 years for mitral and 55 years for aortic valve replacement.
Does a biologic prosthesis improve long-term mortality compared to a mechanical prosthesis in patients undergoing primary aortic-valve or mitral-valve replacement?
Mechanical prostheses are associated with a long-term mortality benefit compared to biologic prostheses up to age 70 for mitral-valve replacement and up to age 55 for aortic-valve replacement.
Tasa de eventos absoluta: 0% vs 0%
The long-term mortality benefit that was associated with a mechanical prosthesis, as compared with a biologic prosthesis, persisted until 70 years of age among patients undergoing mitral-valve replacement and until 55 years of age among those undergoing aortic-valve replacement. (Funded by the National Institutes of Health and the Agency for Healthcare Research and Quality.).
Goldstone et al. (Wed,) reported a other. Mechanical prostheses provided a long-term mortality benefit compared to biologic prostheses up to 70 years for mitral and 55 years for aortic valve replacement.